Rxo (RXO) Depreciation & Amortization (CF) (2021 - 2026)

Rxo (RXO) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $26.0 million the latest figure, recorded in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $26.0 million, down 18.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.0 million (up 6.8% YoY), and the FY2025 annual result was $116.0 million, up 33.33% from the prior year.
• Depreciation & Amortization (CF) was $26.0 million for Q1 2026 at Rxo, down from $28.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $33.0 million in Q4 2024 and troughed at $15.0 million in Q4 2023.
• Average Depreciation & Amortization (CF) over 5 years is $22.5 million, with a median of $21.0 million recorded in 2022.
• Year-over-year, Depreciation & Amortization (CF) plunged 30.43% in 2023 and surged 120.0% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $21.0 million in 2022, then dropped by 28.57% to $15.0 million in 2023, then jumped by 120.0% to $33.0 million in 2024, then decreased by 15.15% to $28.0 million in 2025, then dropped by 7.14% to $26.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $26.0 million in Q1 2026, $28.0 million in Q4 2025, and $26.0 million in Q3 2025.